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This study describes the screening of extracts obtained from 19
species of plants used in Brazilian traditional medicine for
treatment of a variety of diseases. The extracts were tested against
axenic amastigote and promastigote forms of Leishmania (L.)
amazonensis, and epimastigote forms of Trypanosoma cruzi in
vitro at a concentration of 100 µg/ml. Baccharis trimera,
Cymbopogon citratus, Matricaria chamomilla, Mikania glomerata,
Ocimum gratissimum, Piper regnellii, Prunus domestica, Psidium
guajava, Sambucus canadensis, Stryphnodendron adstringens,
Tanacetum parthenium, and Tanacetum vulgare showed significant
effects against one or both parasites, with a percentage of growth
inhibition between 49.5 and 99%. The extracts showed no cytotoxic
effect on sheep erythrocytes. These medicinal plants may be sources
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Leishmaniasis is a disease with diverse clinical
manifestations that depends on both infecting species of
Leishmania and the immune response of the host. Several
syndromes are subsumed under the term leishmaniasis:
most notably visceral, cutaneous and mucosal
leishmaniasis (Herwaldt, 1999). The first-choice treatment
for the several forms of leishmaniasis is pentavalent
antimonials, which are potentially toxic and often
ineffective. Second-line compounds used in treatment of
unresponsive cases generally include pentamidine and
amphotericin B, which may be very toxic (Hepburn et al.,
1994; Berman et al., 1996; Croft et al., 1997).
Trypanosoma cruzi is the etiological agent of Cha-
gas’ disease, which affects 16 to 18 million people in Latin
America and is responsible for the death of more than
45,000 patients per year (WHO, 1997). The chronic phase
typically occurs 10 to 20 years after the parasite is
acquired, and affects 10 to 30% of those infected. It is
transmitted to humans by triatomine bugs or through blood
transfusion (Viotti et al., 1994). Benznidazole and
nifurtimox, the two compounds that have served as the
principal antiparasitic drugs for American trypanosomiasis,
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are not consistently effective and have serious side
effects, including cardiac and renal toxicity, and fail to cure
most patients with chronic disease (Maya et al., 1997;
Veloso et al., 2001). More efficacious drugs are urgently
needed to treat patients with leishmaniasis and Chagas’
disease.
Although the idea that herbal drugs are totally safe
and free from side effects is erroneous, adverse effects
of phytotherapeutic agents are less common compared
with synthetic drugs. Over the last 15 years, interest in
herbal medicines has increased worldwide in both
developed and developing countries (Calixto, 2000).
Because of the immense flora and cultural aspects the
use of plants in the form of crude extracts, infusions or
plasters, is a usual practice to treat common infections in
Brazil (Calixto, 2000). There is a rich local ethnobotanical
bibliography describing the species most frequently used
to cure gastrointestinal, respiratory, and urinary problems
and skin infections (Corrêa, 1932; Cruz, 1979; Plantas que
curam, 1983; Oliveira and Kisue, 1989; Silva and
Sant’ana, 1995; Newall et al., 1996; Biazzi, 1996).
However, there is still a lack of experimental scientific
studies confirming the antibiotic properties of many of
these remedies. In vitro antimicrobial screening methods
furnish the preliminary observations that are necessary
to select, among the crude plant products, those with
potentially useful properties for further chemical and
pharmacological studies.
The immense chemical diversity and range of
bioactivity of plants has led to the development of hundreds
of pharmaceutical drugs. Studies in several countries
including Brazil, Argentina, Bolivia, Mexico, and Colombia
have shown that many plants show activity against T. cruzi
(Muellas-Serrano et al., 2000; Weniger et al., 2001; Abe
et al., 2002; Igweh et al., 2002) and Leishmania (Fournet
et al., 1992; Torres-Santos et al., 1999; Delorenzi et al.,
2001; Ferreira et al., 2002; Salvador et al., 2002).
Extracts derived from plants offer novel possibilities
to obtain new compounds that are active against
protozoans. We report the results of preliminary screening
tests for leishmanicidal and trypanocidal activities of crude
extracts from 19 plants used in Brazilian folk medicine for
treatment of various diseases: Achillea millefolium,
Anacardium occidentale, Baccharis trimera,
Cymbopogon citratus, Erythrina speciosa, Eugenia
uniflora, Lippia alba, Matricaria chamomilla, Mikania
glomerata, Ocimum gratissimum, Piper regnellii,
Prunus domestica, Psidium guajava, Punica
granatum, Sambucus canadensis, Spilanthes acmella,




The plants were collected in Maringá, State of
Paraná in southern Brazil, and identified by comparison
with authenticated specimens and the voucher of each
species was deposited at the herbarium of the State
University of Maringá. Bark of S. adstringens was
collected in São Jerônimo da Serra, Paraná and a voucher
herbarium specimen was deposited in the same herbarium.
Aerial parts of T. parthenium (Lot 166871) was furnished
by Herbarium Laboratório Botânico Ltda.
Preparation of extracts
The plant parts were dried at room temperature,
pulverised, and then macerated in ethanol:water (90:10) for
48 h at 25 ºC in the dark. The hydroalcoholic extract thus
obtained was evaporated under vacuum and lyophilised, and
the residue was directly assayed against the microorganisms.
Bark samples from S. adstringens were dried in the
dark at room temperature, powdered, and extracted by
turbo-extraction in 70% acetone. Next, the crude acetone
extract was evaporated under reduced pressure and
lyophilised (Mello et al., 1996).
Leishmanicidal activity in vitro
For experiments, promastigote forms of the MHOM/
BR/75/Josefa strain of L. amazonensis were inoculated
in Warren´s medium (brain-heart infusion plus hemin and
folic acid) supplemented with 10% of inactivated fetal
bovine serum (Gibco Invitrogen Corporation, New York,
USA) containing different extracts (100 µg/ml), which
were added only once to the cultures. Cells were grown in
a 24-well plate with each well containing 1 ml of the
medium. The starting inocula consisted of protozoans in
logarithmic growth phase (1 x 106 cells/ml). After 72 h at
28 ºC, cell growth was estimated by counting in a
haemocytometer (Improved Double Neubauer). All
experiments were performed in duplicate, and the results
expressed as log number cells/ml and as the percentage of
growth inhibition. The extracts tested were dissolved in
dimethyl sulfoxide (DMSO), of which the final
concentration did not exceed 1% (Yong et al., 2000).
Axenic amastigote cultures, obtained by in vitro
transformation of infective promastigotes, were
maintained in Schneider’s insect medium (Sigma Chemical
Co., St. Louis, Missouri, USA), pH 4.5, with 20% fetal
bovine serum at 32 oC (Ueda-Nakamura, 2001).
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Trypanocidal activity in vitro
Epimastigote forms of T. cruzi Y strain were grown
in liver infusion tryptose (LIT) medium supplemented with
10% inactivated fetal bovine serum and assayed with crude
extracts (100 µg/ml). The extracts were dissolved in 1%
DMSO, a concentration which did not affect the growth of
the parasites. Next, 1x106 protozoa/ml was introduced into
24-well plate each containing 1 ml of diluted extract. Cell
growth was determined by counting the parasites with a
Neubauer haemocytometer after incubation for 96 h at
28 oC. Assays were performed in duplicate on separate
occasions.
Red blood cell (RBC) lysis assay
A suspension of freshly defibrinised sheep blood was
prepared by adding 2.0 ml of blood to 48.0 ml sterile 5%
glucose. Stock solutions of crude extracts solubilized in
DMSO were further diluted with sterile 5% glucose to
yield final test concentrations of 10 to 1,000 µg/ml. One
millilitre of RBC suspension was added and gently mixed,
and the tubes were incubated at 37 oC. Haemolysis of
erythrocytes was indicated by + 25%; ++ 50%; +++ 75%; and
++++ 100% lysis. Minimum lytic concentration (MLC) is
defined as the lowest concentration of a test compound
which produces complete or partial lysis of erythrocytes.
These tests were performed in duplicate on separate
occasions.
RESULTS AND DISCUSSION
This study demonstrated that crude extracts from
several species of plants inhibited the growth of both
Leishmania (L.) amazonensis and Trypanosoma cruzi.
The 19 plant species evaluated, all traditionally used for
treatment of various diseases, are listed in Table I.
Numerous extracts of Brazilian medicinal plants have
been screened for their antibacterial, antifungal,
molluscicidal, antiprotozoal or antiviral activities (Mendes
et al., 1999; Alves et al., 2000; Holetz et al., 2002; Bedoya
et al., 2002). The ethnobotanical screening tests of crude
extracts on growth inhibition of L. amazonensis and T.
cruzi are shown in Table II. The hydroalcoholic extracts
of the plants C. citratus, M. chamomilla, P. regnellii, T.
parthenium, and T. vulgare were the most active against
both protozoans, reaching high levels of growth inhibition
(over 90%) at 100 µg/ml. Previous studies have
demonstrated that these plants exhibit antimicrobial and
anti-inflammatory activity. The essential oil and
sesquiterpene lactones of T. vulgare displayed
antibacterial activity (Abad et al., 1995). Holetz et al.
(2002) demonstrated antimicrobial activity of extracts of
P. regnellii  against the gram-positive bacteria
Staphylococcus aureus and Bacillus subtilis. Recently,
Pessini et al. (2005) isolated 4 neolignans from leaves of
the P. regnellii var. pallescens and reported the antifungal
activity of the compound conocarpan. Eupomatenoid-7
(neolignan) and fragransin E1 (lignan) isolated from
Aristolochia taliscana immobilized epimastigote forms of
T. cruzi (Abe et al., 2002). Extract of M. chamomilla
showed anti-inflammatory activity on intact rats inhibiting
41.1% of the paw edema volume. The major constituents
of this plant are volatile oils, apigenin, choline
umbelliferone, tricontane, phytosterol, anthemic acid,
anthemidin azulene, tannin and nicotinic acid (Al-Hindawi
et al. 1989). Two hydroxyflavones isolated from leaves
and flowers of T. vulgare inhibit the pathways of
arachidonate metabolism in mixed peritoneal leucocytes
from Wistar rats and reduced inflammation (Williams et al.,
1999). Laboratory evidence indicates that T. parthenium
extract causes vasodilatation; inhibit phagocytosis, platelet
aggregation and secretion of inflammatory mediators
(Heptinstall et al., 1985).
Against amastigote forms of L. amazonensis,
extracts from three other plants, M. glomerata, O.
gratissimum, and P. domestica also gave excellent results,
with 97.5, 91.5, and 90.0% growth inhibition, respectively.
These plants are antimicrobial and anti-inflammatory
agents. An ethanol extract of M. glomerata is effective in
inhibiting immunologic inflammation (Fierro et al., 1999),
essential oil from O. gratissimum exhibits antibacterial
activity in vitro (Nakamura et al., 1999), and extracts from
fruits of P. domestica  are effective against
Staphylococcus aureus and the fungi Scopulariopsis
spp. (Stacewicz-Sapuntzakis et al., 2001). Baccharis
trimera showed moderate activity against both axenic
amastigote and promastigote forms of L. amazonensis
and the epimastigote form of T. cruzi, with 64.6, 58.3, and
65.8% growth inhibition, respectively.
Leishmania (L.) amazonensis appeared to be more
sensitive than T. cruzi to some of the extracts assayed.
Extracts of O. gratissimum, P. domestica, P. guajava,
and S. canadensis showed growth inhibition between 52
and 91.5% in L. amazonensis, whereas these extracts
were only weakly active against T. cruzi. In preceding
studies, Muelas-Serrano et al. (2000) observed that
aqueous extracts of B. trimera and P. guajava showed no
activity against T. cruzi and Trichomonas vaginalis. On
the other hand, S. adstringens showed growth inhibition
of 51.9% for T. cruzi, and was weakly active against L.
amazonensis, with growth inhibition lower than 36.5%.
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TABLE I - Traditional use of species selected for antiprotozoan investigation
Scientific name Family Voucher number Local name Part used Use
Achillea . Asteraceae HUM8424 Mil folhas Leaf Flowers and leaves are used
millefolium L to treat wounds, ulcers,
diarrhoeae, skin injuries,
gastrintestinal disorders, flu,
fever and urinary afectionsc,d,e
Anacardium Anacardiaceae HUM 10154 Caju Leaf This plant is used to treat
occidentale L. gastrointestinal, respiratory
and skin infection b
Baccharis trimera Asteraceae HUM 10152 Carqueja Leaf Leaf are used for treatment
(Less.) DC. of gastrointestinal and
respiratory afections, fever
and rheumatism b
Cymbopogon Gramineae HUM 520 Capim limão Leaf Used to treat fever and
citratus (DC.) gastrointerstinal diseases a
Stapf
Erythrina speciosa Leguminosae HUM 8416 Eritrina Stem The tradicional
Andrews Papilionidae usage indicates that Erythrina
species could have analgesic,
anti-inflamatory and
antibacterial activiy d






Lippia alba (Mill.) Verbenaceae HUM 8421 Erva-cidreira Leaf Its leaves are









are used for treatment of
fever, and skin injuries b, c
Mikania Asteraceae HUM 8420 Guaco Leaf Leaves infusion used as
glomerata Spreng. antiseptic, anti-inflamatory
and antibacterial e, f, g
Ocimum Labiatae HUM 10151 Alfavaca Leaf Leaves infusion are used for




cough and fever a, b
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TABLE I - cont.
Scientific name Family Voucher number Local name Part used Use
Piper regnellii Piperaceae HUM 8392 Pariparoba Leaf Leaf and root are used in the
(Miq.) C.DC. form of crude extracts,





afections and skin infections b
Prunus domestica L. Rosaceae HUM 10153 Ameixa Leaf Leaves are used to treat
some infections specially
within the alimentary tract
and respiratory disease b
Psidium guajava L. Myrtaceae HUM 8423 Goiaba Leaf Leaf, root and bark extracts
are used for treatment of
diarrhoeae, leukorrhoeae,
cholera, external ulcers and
skin diseases e





Sambucus Caprifoliaceae HUM 8422 Sabugueiro Leaf Leaf, flower, and fruit
canadensis L. extracts of parts of these
plants have been used for
respiratoty and pulmonary
disorders (cold, coughs, etc.)
and antinflamatory topic c, e, g
Spilanthes acmella Asteraceae HUM 8418 Jambu Leaf A decoction or infusion of




urinary infection and throat
complaints b, e
Stryphnodendron Leguminosae HUM 3800 Barbatimão Bark Bark is used for treatment of
adstringens (Mart.) leucorrhoea, diarrhea and as
Coville anti-inflamatory g
Tanacetum Asteraceae L166871 Tanaceto Aerial This plant is used against
parthenium (L.) Parts headache, fever,
Sch. Bip. stomachache, toothache,
insect bites c
Tanacetum Asteraceae HUM 8425 Erva dos Leaf Leaves, flowers
vulgare L. Vermes and seeds are recommended
as anti-inflammatory,
carminative, helminth
infections and colic a, c
a Corrêa, M. P., 1932; b Plantas que curam, 1983; c Newall et al., 1996; d Cruz, C. N., 1979; e Silva I.; Sant’ana, D. M.
G., 1995; f Oliveira, P.; Kisue, G., 1989; g Biazzi, E. S., 1996.
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Herzog-Soares et al. (2002) demonstrated that an ethanol
extract of stem bark from S. adstringens decreased the
number of trypomastigote forms of T. cruzi in the blood of
mice treated with this extract.
Hydroalcoholic extracts of A. millefolium, A.
occidentale, E. speciosa, E. uniflora, L. alba, P.
granatum, and S. acmella were inactive against both L.
amazonensis and T. cruzi, at 100 µg/ml. An ethyl-acetate
extract of E. uniflora had the highest activity against both
a drug-sensitive and a multi-drug-resistant clone of
Trypanosoma congolense (Adewunmi et al., 2001). The
medium containing 1% DMSO, negative control, did not
affect the growth of the protozoa. Amphotericin B was
used as positive control against L. amazonensis and
showed 90% of growth inhibition at concentration of
0.116 µg/ml. The positive control against T. cruzi was
Benznidazole at 10 µg/ml that showed 80% of growth
inhibition.
Natural products such as alkaloids, terpenes,
quinones, and polyphenols have shown potent growth
inhibition of T. cruzi or Leishmania brasiliensis (Wright
and Phillipson, 1990). Some Nigerian medicinal plants have
been screened for trypanocidal properties (Adewunmi et
al., 2001). Their extracts showed good activity against
Trypanosoma brucei and Trypanosoma congolense,
suggesting that they might be a potential source of new and
selective agents for the treatment of diseases caused by
these protozoans. Recently, Weniger et al. (2001) reported
on antiprotozoal activity of Colombian plants against
several strains of Plasmodium falciparum, Leishmania
sp. and T. cruzi.
An important criterion in the search for compounds
active against L. amazonensis and T. cruzi  with
therapeutic potential, is to determine whether they show
toxic effects on mammalian host cells. For this purpose, a
test of cytotoxicity to sheep erythrocytes was performed
in order to determine the ratio of selectivity to biological
activity. The haemolytic effects of the crude extracts on
sheep blood are shown in Table III. Except B. trimera,
none of the crude extracts showed any haemolytic effect
at 100 µg/ml after 60 minutes of incubation.
We suggest that the biological efficacy at this
concentration is not due to in vitro cytotoxicity. B. trimera,
M. glomerata, and T. parthenium showed no more than
25% lysis after 120 min of incubation. However, the
extracts of A. occidentale, B. trimera, C. citratus, L.
alba, M. chamomilla, M. glomerata, O. gratissimum, P.
regnellii, and T. parthenium showed haemolytic activity
TABLE II - Effect of plant extracts on the growth of Leishmania (L.) amazonensis and Trypanosoma cruzi
                                                                      % Growth inhibition
Leishmania (L.) amazonensis Trypanosoma cruzi
Promastigote Amastigote Epimastigote
Achillea millefolium L. 11.6 ± 0.3 48.2 ± 6.3 39.8 ± 4.5
Anacardium occidentale 5.4 ± 7.2 32.3 ± 10.4 9.4 ± 0.5
Baccharis trimera (Less) D.C. 58.3 ± 8.2 64.6 ± 8.4 65.8 ± 1.1
Cymbopogon citratus 98.0 ± 0.5 95.2 ± 5.6 79.5 ± 6.4
Erythrina speciosa Andrew 5.1 ± 3.6 28.4 ± 8.0 26.0 ± 2.8
Eugenia uniflora L. 38.0 ± 3.8 51.6 ± 0.8 34.3 ± 4.6
Lippia alba (Mill.) N.E.Br 8.5 ± 5.9 57.5 ± 8.3 36.5 ± 0.7
Matricaria chamomilla 98.1 ± 0.6 92.7 ± 2.0 95.0 ± 2.8
Mikania glomerata Spreng 52.5 ± 11.2 97.5 ± 2.6 49.5 ± 3.5
Ocimum gratissimum 54.7 ± 0.6 91.5 ± 2.0 28.3 ± 4.2
Piper regnellii Miq. 98.2 ± 0.5 96.8 ± 3.7 89.7 ± 6.7
Prunus domestica 42.2 ± 5.0 90.0 ± 7.1 5.9 ± 5.2
Psidium guajava L. 65.4 ± 5.4 52.0 ± 2.1 15.6 ± 4.4
Punica granatum L. 69.1 ± 4.4 9.1 ± 3.0 11.2 ± 1.8
Sambucus canadensis L. 65.7 ± 6.4 54.9 ± 0.6 13.8 ± 6.8
Spilanthes acmella Mart. 4.3 ± 0.8 18.1 ± 7.1 9.3 ± 4.6
Stryphnodendron adstringens Mart 36.5 ± 0.5 21.0 ± 0.6 51.9 ± 0.2
Tanacetum parthenium 96.5 ± 0.2 94.3 ± 4.0 93.0 ± 1.4
Tanacetum vulgare L. 96.4 ± 3.4 99.0 ± 1.0 95.5 ± 3.5
Values represent the mean ± S.D. of duplicate determination
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at concentrations of more than 500 µg/ml. As reported by
Lee et al. (1999), amphotericin B showed strong
haemolytic activity with 50% lysis at 25 µg/ml within 60
min of incubation. The control with Triton X-114 showed
a strong haemolytic effect with 100% lysis after 60 min,
while 1% DMSO did not cause lysis.
CONCLUSION
The results of the present study confirmed that the
use of medicinal plants in folk medicine contributes
significantly to primary health care, and that natural
products are potential sources of new and selective agents
for the treatment of important tropical diseases caused by
protozoans. Further laboratory and clinical studies of these
plants are required in order to understand their
antiprotozoal principles. Therefore, the most promising
extracts were prioritised for further phytochemical analysis
on the isolation and the identification of the active
compounds with antiprotozoal activity, a work that is
already under way.
RESUMO
Efeito de extratos de plantas medicinais no cresci-
mento de Leishmania (L.) amazonensis e
Trypanosoma cruzi
Este estudo descreve a triagem de extratos obtidos de
19 espécies de plantas usadas na medicina tradicional
brasileira para o tratamento de várias doenças. Os
extratos foram testados contra formas amastigota
axênica e promastigota de Leishmania (L.)
amazonensis, e formas epimastigota de Trypanosoma
cruzi in vitro na concentração de 100 µg/ml. Baccharis
trimera, Cymbopogon citratus, Matricaria chamomilla,
Mikania glomerata, Ocimum gratissimum, Piper regnellii,
Prunus domestica, Psidium guajava, Sambucus canadensis,




1000 500 100 1000 500 100
Achillea millefolium 0 0 0 0 0 0
Anacardium occidentale 0 0 0 ++ ++ 0
Baccharis trimera ++++ ++ + ++++ +++ +
Cymbopogon cytratus 0 0 0 ++ 0 0
Erythrina speciosa 0 0 0 + 0 0
Eugenia uniflora 0 0 0 + 0 0
Lippia alba ++++ +++ 0 ++++ +++ 0
Matricaria chamomilla 0 0 0 +++ 0 0
Mikania glomerata + 0 0 +++ ++ +
Ocimum gratissimum + 0 0 +++ 0 0
Piper regnellii 0 0 0 +++ + 0
Prunus domestica 0 0 0 0 0 0
Psidium guajava 0 0 0 + 0 0
Punica grantum 0 0 0 0 0 0
Sambucus canadensis 0 0 0 +++ 0 0
Spilanthes acmella 0 0 0 +++ 0 0
Stryphnodendron adstringens 0 0 0 0 0 0
Tanacetum parthenium +++ +++ 0 +++ +++ +
Tanacetum vulgare 0 0 0 ++ + 0
Amphotericin B* ++++ ++++ +++ ++++ ++++ +++
++++ = 100% lysis; +++ = 75% lysis; ++ = 50% lysis; + = 25% lysis; 0 = no lysis
Minimum lytic concentration at 60 min = 25 mg/ml; 120 min = 12.5 mg/ml
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Stryphnodendron adstringens, Tanacetum parthenium, e
Tanacetum vulgare apresentaram efeito significante
contra um ou ambos parasitas, com a porcentagem de
inibição de crescimento entre 49,5 e 99%. Os extratos
não mostraram efeito citotóxico em hemácias de car-
neiro. Essas plantas medicinais podem ser fontes alter-
nativas de novos compostos clinicamente ativos con-
tra L. amazonensis e T. cruzi.
UNITERMOS:  Leishmania (L.) amazonensis.
Trypanosoma cruzi. Extratos de plantas. Triagem
farmacológica.
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